- Investing Ideas
- Danish Pharmaceuticals & Biotech Potentially Undervalued Companies
Danish Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
5
Companies with a Value score of at least 3, ordered by Value score
5 companies
Bavarian Nordic
Market Cap: DKK 15.8b
Develops, manufactures, and supplies life-saving vaccines.
BAVA
DKK 209.40
7D
11.5%
1Y
-11.9%
H. Lundbeck
Market Cap: DKK 40.6b
Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.
HLUN B
DKK 41.04
7D
-4.9%
1Y
5.1%
Novo Nordisk
Market Cap: DKK 1.3t
Engages in the research and development, manufacture, and distribution of pharmaceutical products.
NOVO B
DKK 300.85
7D
2.9%
1Y
-18.1%
H. Lundbeck
Market Cap: DKK 40.6b
Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.
HLUN A
DKK 40.50
7D
11.3%
1Y
25.2%
Strategic Partners
Market Cap: DKK 29.2m
Does not have significant operations.
STRAP
DKK 700.00
7D
-6.0%
1Y
-32.7%